Related references
Note: Only part of the references are listed.Dopamine Receptor Ligands. Part 18: Modification of the Structural Skeleton of Indolobenzazecine-Type Dopamine Receptor Antagonists
Dina Robaa et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Dibenzazecine scaffold rebuilding-Is the flexibility always essential for high dopamine receptor affinities?
Maria Schulze et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Dopamine/Serotonin receptor ligands.: 16.: expanding dibenz[d,g]azecines to 11- and 12-membered homologues.: Interaction with dopamine D1-D5 receptors
Christoph Enzensperger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Dopamine/serotonin receptor ligands.: 12:: SAR studies on hexahydro-dibenz[d,g]azecines lead to 4-chloro-7-methyl-5,6,7,8,9,14-hexahydrodibenz[d,g]azecin-3-ol, the first picomolar D5-selective dopamine-receptor antagonist
P Mohr et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Dopamine/serotonin receptor ligands.: 10:: SAR studies on azecine-type dopamine receptor Ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist
B Hoefgen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Highly efficient catalysts for epoxidation mediated by iminium salts
PCB Page et al.
SYNTHESIS-STUTTGART (2005)
Dopamine D1/D5 receptor antagonists with improved pharmacokinetics:: Design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists
WL Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists
MYS Kalani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Structure and function of dopamine receptors
D Vallone et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2000)
Share Paper
